|
TMEFF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.98470000001283E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.016600E-03 |
| Normal-vs-Stage2 |
3.672400E-02 |
| Normal-vs-Stage3 |
2.654500E-02 |
| Normal-vs-Stage4 |
5.672300E-02 |
| Stage1-vs-Stage2 |
2.939600E-01 |
| Stage1-vs-Stage3 |
6.924200E-02 |
| Stage1-vs-Stage4 |
3.636400E-01 |
| Stage2-vs-Stage3 |
1.777800E-01 |
| Stage2-vs-Stage4 |
9.203000E-01 |
| Stage3-vs-Stage4 |
2.032200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.95783999999977E-05 |
| Normal-vs-AfricanAmerican |
2.028000E-02 |
| Normal-vs-Asian |
1.449440E-01 |
| Caucasian-vs-AfricanAmerican |
5.799600E-01 |
| Caucasian-vs-Asian |
6.695200E-01 |
| AfricanAmerican-vs-Asian |
9.073400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.777500E-03 |
| Normal-vs-Female |
5.71280000000174E-05 |
| Male-vs-Female |
1.568300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.883700E-03 |
| Normal-vs-Extreme_Weight |
4.680000E-02 |
| Normal-vs-Obese |
1.289530E-02 |
| Normal-vs-Extreme_Obese |
2.409400E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.257630E-01 |
| Normal_Weight-vs-Obese |
8.601600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.965800E-01 |
| Extreme_Weight-vs-Obese |
1.568830E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.604200E-01 |
| Obese-vs-Extreme_Obese |
4.515400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.217500E-02 |
| Normal-vs-Age(41-60Yrs) |
5.765100E-04 |
| Normal-vs-Age(61-80Yrs) |
1.900110E-03 |
| Normal-vs-Age(81-100Yrs) |
2.320000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.173600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.391600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.348800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.624000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.554200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.928400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.120200E-02 |
| Normal-VS-Type2 PRCC |
1.055660E-03 |
| Normal-VS-KIRP CIMP |
1.324050E-01 |
| Normal-VS-Unclassified PRCC |
1.493610E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.544400E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.573800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.386400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.407620E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.471800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.251970E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.651970E-02 |
| Normal-vs-N1 |
6.703700E-03 |
| Normal-vs-N2 |
2.782200E-01 |
| N0-vs-N1 |
9.109200E-01 |
| N0-vs-N2 |
8.992800E-01 |
| N1-vs-N2 |
7.783200E-01 |
|
|
